GS
Top 0.01% — Titan
Gregg Semenza
Genetics · Genetics
Baltimore, United States
185 H-Index
35,106 Citations
3,017 Total Impact
GLNobel Prize in Physiology or Medicine (2019)0
GLLasker Award (2016)0
Overview
Gregg Semenza is a genetics specialist at Johns Hopkins University. Based in Baltimore.
For Patients
- Pioneered the HIF-1 discovery, a technique still used by doctors worldwide
- Research is cited 35K+ times by other doctors and scientists, indicating significant influence on medical research
- Currently at Johns Hopkins University in Baltimore, United States
Biography
Gregg Semenza is an American geneticist who discovered HIF-1, the master regulator of cellular oxygen sensing. Nobel Prize 2019.
Affiliations & Institutions
Research Impact
10 Publications
35,106 Total Citations
10K+ Citation Milestone
Publication Timeline
Published In
Nature reviews. CancerProceedings of the National Academy of SciencesMolecular and Cellular BiologyCell MetabolismCell
Key Publications
Targeting HIF-1 for cancer therapy
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Hypoxia-Inducible Factors in Physiology and Medicine
Areas of Expertise
Pioneering Techniques
Medical Specialties
Clinical Knowledge & Procedures
Legacy Timeline
The life and contributions of Gregg Semenza
1995
Discovered HIF-1
Identified hypoxia-inducible factor 1, the master regulator of oxygen homeostasis
2019
Nobel Prize
For discoveries of how cells sense and adapt to oxygen availability